Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tricuspid Valve Insufficiency | 2 | 2020 | 355 | 0.960 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2020 | 1419 | 0.690 |
Why?
|
| Endocarditis, Bacterial | 2 | 2023 | 445 | 0.610 |
Why?
|
| Endocarditis | 2 | 2023 | 351 | 0.600 |
Why?
|
| Aortic Valve Stenosis | 5 | 2022 | 2065 | 0.600 |
Why?
|
| Foramen Ovale, Patent | 2 | 2016 | 214 | 0.550 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 584 | 0.470 |
Why?
|
| Lipoxins | 3 | 2009 | 418 | 0.400 |
Why?
|
| Malnutrition | 1 | 2018 | 640 | 0.400 |
Why?
|
| Heart Valve Prosthesis | 1 | 2018 | 1495 | 0.340 |
Why?
|
| Aortic Valve | 4 | 2021 | 1996 | 0.340 |
Why?
|
| Heart Diseases | 1 | 2018 | 2809 | 0.240 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3201 | 0.220 |
Why?
|
| Ventricular Remodeling | 2 | 2022 | 1261 | 0.210 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2008 | 2282 | 0.200 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2022 | 329 | 0.180 |
Why?
|
| Docosahexaenoic Acids | 1 | 2007 | 912 | 0.170 |
Why?
|
| Stroke | 3 | 2022 | 9962 | 0.160 |
Why?
|
| Running | 1 | 2023 | 483 | 0.160 |
Why?
|
| Surgical Instruments | 1 | 2020 | 385 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 3726 | 0.130 |
Why?
|
| Atrial Septum | 1 | 2016 | 61 | 0.130 |
Why?
|
| Aspirin | 1 | 2007 | 3364 | 0.120 |
Why?
|
| Frail Elderly | 1 | 2018 | 752 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2019 | 1577 | 0.110 |
Why?
|
| Peritonitis | 3 | 2009 | 369 | 0.100 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2007 | 613 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15757 | 0.100 |
Why?
|
| Babesiosis | 1 | 2013 | 92 | 0.100 |
Why?
|
| Cardiology | 1 | 2022 | 1723 | 0.090 |
Why?
|
| Aorta | 1 | 2019 | 2039 | 0.090 |
Why?
|
| Inflammation | 2 | 2009 | 10756 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2009 | 1796 | 0.090 |
Why?
|
| Heart | 1 | 2022 | 4393 | 0.080 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2009 | 146 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 3880 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2021 | 3598 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3527 | 0.080 |
Why?
|
| Benzene Derivatives | 1 | 2008 | 53 | 0.080 |
Why?
|
| Humans | 22 | 2023 | 760621 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2022 | 5523 | 0.070 |
Why?
|
| Eicosanoids | 1 | 2009 | 278 | 0.070 |
Why?
|
| Neutrophil Infiltration | 2 | 2008 | 393 | 0.070 |
Why?
|
| Neutrophils | 4 | 2009 | 3767 | 0.070 |
Why?
|
| Cell Migration Inhibition | 1 | 2007 | 97 | 0.070 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2007 | 92 | 0.070 |
Why?
|
| Lyme Disease | 1 | 2013 | 630 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2009 | 554 | 0.070 |
Why?
|
| Cannabinoids | 1 | 2009 | 173 | 0.070 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2006 | 31 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2007 | 617 | 0.070 |
Why?
|
| Chemokines | 2 | 2007 | 962 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 488 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1347 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 655 | 0.060 |
Why?
|
| Remission Induction | 1 | 2009 | 2392 | 0.060 |
Why?
|
| Dental Calculus | 1 | 2023 | 12 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2007 | 732 | 0.050 |
Why?
|
| Oral Hygiene | 1 | 2023 | 129 | 0.050 |
Why?
|
| 15-Oxoprostaglandin 13-Reductase | 1 | 2001 | 5 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 6659 | 0.050 |
Why?
|
| Male | 10 | 2022 | 359744 | 0.050 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2001 | 169 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10827 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2001 | 364 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7269 | 0.040 |
Why?
|
| Aged | 6 | 2022 | 169152 | 0.040 |
Why?
|
| Mice | 7 | 2009 | 81208 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 1881 | 0.040 |
Why?
|
| Echocardiography | 2 | 2021 | 4981 | 0.030 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2022 | 571 | 0.030 |
Why?
|
| Embolism, Paradoxical | 1 | 2016 | 55 | 0.030 |
Why?
|
| Female | 7 | 2022 | 391270 | 0.030 |
Why?
|
| Cell Movement | 1 | 2007 | 5206 | 0.030 |
Why?
|
| Macrophages | 1 | 2009 | 5745 | 0.030 |
Why?
|
| Microcirculation | 1 | 2019 | 1278 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2009 | 18957 | 0.030 |
Why?
|
| Animals | 8 | 2009 | 167963 | 0.030 |
Why?
|
| Models, Biological | 1 | 2009 | 9467 | 0.030 |
Why?
|
| Cell Line | 1 | 2007 | 15620 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 704 | 0.020 |
Why?
|
| Apoptosis | 1 | 2006 | 9501 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 10181 | 0.020 |
Why?
|
| Drug Stability | 1 | 2008 | 290 | 0.020 |
Why?
|
| Fatty Alcohols | 1 | 2007 | 22 | 0.020 |
Why?
|
| Glycols | 1 | 2007 | 55 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15289 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8469 | 0.020 |
Why?
|
| Fatigue | 1 | 2013 | 1544 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2008 | 412 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6465 | 0.020 |
Why?
|
| Fever | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58995 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2023 | 22053 | 0.020 |
Why?
|
| Medicare | 1 | 2022 | 6786 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15840 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2013 | 2415 | 0.010 |
Why?
|
| Drug Design | 1 | 2008 | 1061 | 0.010 |
Why?
|
| Niflumic Acid | 1 | 2001 | 10 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 74359 | 0.010 |
Why?
|
| Diclofenac | 1 | 2001 | 67 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2007 | 14372 | 0.010 |
Why?
|
| Indomethacin | 1 | 2001 | 326 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3620 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39261 | 0.010 |
Why?
|
| Ligands | 1 | 2007 | 3276 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1652 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15687 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4090 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 22023 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12965 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54303 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6538 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 5434 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 65017 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 4354 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72461 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 7343 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80372 | 0.010 |
Why?
|
| Lung | 1 | 2006 | 9994 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 220352 | 0.000 |
Why?
|
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_